{
    "name": "triheptanoin",
    "comment": "Rx",
    "other_names": [
        "Dojolvi"
    ],
    "classes": [
        "Metabolic & Endocrine",
        "Other"
    ],
    "source": "https://reference.medscape.com/drug/dojolvi-triheptanoin-4000038",
    "pregnancy": {
        "common": [
            "No data available on use in pregnant females ",
            "Advise females to report pregnancies to Ultragenyx Pharmaceutical Inc at 1-888-756-8657"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "There are no data on the presence of triheptanoin or its metabolites in human or animal milk, effects on breastfed infants, or effects on milk production",
            "MCT and other fatty acids are normal components of breastmilk and the composition of breastmilk varies within feedings, over stages of lactation, and between mothers and populations, owing to maternal factors including genetics, environment, and diet"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Feeding tube performance and functionality can degrade over time depending on usage and environmental conditions ",
                "Avoid use with pancreatic insufficiency; low or absent pancreatic enzymes may result in reduced heptanoate absorption, and subsequently lead to insufficient medium-chain fatty acid supplementation "
            ],
            "specific": [
                {
                    "type": "Drug interaction overview",
                    "description": [
                        "Avoid coadministration with pancreatic lipase inhibitors (eg, orlistat), owing to reduced efficacy and reduced exposure to heptanoate (triheptanoin metabolite) "
                    ]
                }
            ]
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "orlistat",
            "description": {
                "common": "orlistat decreases effects of triheptanoin by Other (see comment). Avoid or Use Alternate Drug. \nComment: Coadministration of triheptanoin with orlistat may reduce exposure to the triheptanoin metabolite, heptanoate, and decrease the effects of triheptanoin."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Abdominal pain",
            "percent": "60"
        },
        {
            "name": "Diarrhea",
            "percent": "44"
        },
        {
            "name": "Vomiting",
            "percent": "44"
        },
        {
            "name": "Nausea",
            "percent": "14"
        }
    ]
}